# Protara Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/protara-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:43.578776+00:00 | | Last reviewed | 2026-10-17T04:46:43.578776+00:00 | ## Identity - Legal name: Protara Therapeutics, Inc. - Display name: Protara Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:46:43.578776+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 9 | | Committees | 6 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Barry Flannelly, Pharm.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:5 - Cynthia Smith: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6 - Gregory Sargen: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7 - Jane Huang, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:8 - Jesse Shefferman: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:9 - Luke Beshar: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10 - Michael Solomon, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:11 - Richard Levy, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:12 - Roger Garceau, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:13 ## Committees - Audit (audit). Chair: Gregory Sargen. Members: Gregory Sargen (chair, current); Luke Beshar (member, current). committee_id=alpha:committee:protara-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Gregory Sargen (member, current). committee_id=alpha:committee:protara-therapeutics-inc:audit-chair - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Luke Beshar (member, current). committee_id=alpha:committee:protara-therapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Cynthia Smith. Members: Cynthia Smith (chair, current). committee_id=alpha:committee:protara-therapeutics-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Cynthia Smith (member, current). committee_id=alpha:committee:protara-therapeutics-inc:compensation-chair - Nominating and Governance (nominating_governance). Chair: Luke Beshar. Members: Luke Beshar (chair, current). committee_id=alpha:committee:protara-therapeutics-inc:nominating-and-governance ## Executive leadership - Mary J. Grendell: Corporate Secretary [CORPORATE_SECRETARY]. Status: current. claim_id=alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Mary J. Grendell executive of Protara Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:3p65hs13pl35u - DIRECTOR_APPOINTED: Cynthia Smith seat on Protara Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:12gw2sjo76qg7 - DIRECTOR_APPOINTED: Jane Huang, M.D. seat on Protara Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:4ao5uj1xj03at - COMMITTEE_CREATED: Compensation · Chair committee of Protara Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1g9q5od1koonej - COMMITTEE_MEMBER_ADDED: Cynthia Smith member of Compensation · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:34bawefgm4zm - DIRECTOR_APPOINTED: Barry Flannelly, Pharm.D. seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1vbm3651fm1dlh - DIRECTOR_APPOINTED: Gregory Sargen seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1a5z5xjekvug7 - DIRECTOR_APPOINTED: Jesse Shefferman seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1k2pywx1ja4d5t - DIRECTOR_APPOINTED: Luke Beshar seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1riufzz175zr99 - DIRECTOR_APPOINTED: Michael Solomon, Ph.D. seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:4eo47i95dj9o - DIRECTOR_APPOINTED: Richard Levy, M.D. seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1v8d7gv1p6ck0b - DIRECTOR_APPOINTED: Roger Garceau, M.D. seat on Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1fvc2ny1pa7izu - COMMITTEE_CREATED: Audit · Chair committee of Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1y7walfuher8f - COMMITTEE_MEMBER_ADDED: Gregory Sargen member of Audit · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:lpizzb1rsmsvn - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Protara Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:gjck7xstrfu1 - COMMITTEE_MEMBER_ADDED: Luke Beshar member of Audit; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1rfobnp1lf2533 ## Scoped resources - `alpha://company/protara-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record - `alpha://company/protara-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=identity - `alpha://company/protara-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/protara-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=board - `alpha://company/protara-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=committees - `alpha://company/protara-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=leadership - `alpha://company/protara-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=ownership - `alpha://company/protara-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=financials - `alpha://company/protara-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/protara-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=compensation - `alpha://company/protara-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=governance - `alpha://company/protara-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/protara-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=audit - `alpha://company/protara-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=legal - `alpha://company/protara-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=risk - `alpha://company/protara-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=cyber - `alpha://company/protara-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/protara-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=agents - `alpha://company/protara-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/protara-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=events - `alpha://company/protara-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=relationships - `alpha://company/protara-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=assessments - `alpha://company/protara-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:gregory-sargen","name":"Gregory Sargen"},"source_id":"board_seats"}` - Claim alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:luke-beshar","name":"Luke Beshar"},"source_id":"board_seats"}` - Claim alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"source_id":"board_seats"}` - Claim alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:luke-beshar","name":"Luke Beshar"},"source_id":"board_seats"}` ## Leadership - Barry Flannelly, Pharm.D.: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Cynthia Smith: Director, Compensation · Chair. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Gregory Sargen: Director, Audit · Chair. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Jane Huang, M.D.: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Jesse Shefferman: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Luke Beshar: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Michael Solomon, Ph.D.: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Richard Levy, M.D.: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Roger Garceau, M.D.: Director. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d. - Mary J. Grendell: Corporate Secretary. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:14. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce642dfe3e076efdaac5bf8fdc70f976f8d75dbdf3846d694ff3b1eb64857e66. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Gregory Sargen; Members Gregory Sargen (Chair); Luke Beshar. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. - Compensation: Chair Cynthia Smith; Members Cynthia Smith (Chair). Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. - Nominating and Governance: Chair Luke Beshar; Members Luke Beshar (Chair). Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Protara Therapeutics, Inc.. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:872b6c23772330f15b40470383646283343d13a2212d7677e6ad4bd2142881fd. ## Entity Status - Public listing published. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:872b6c23772330f15b40470383646283343d13a2212d7677e6ad4bd2142881fd. ## Published Fact - US. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:872b6c23772330f15b40470383646283343d13a2212d7677e6ad4bd2142881fd. ## Committee Appointment - Gregory Sargen: chair, Audit. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. - Luke Beshar: member, Audit. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. - Cynthia Smith: chair, Compensation. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. - Luke Beshar: chair, Nominating and Governance. Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545. ## Security Listing - TARA (NASDAQ). Claim: alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:872b6c23772330f15b40470383646283343d13a2212d7677e6ad4bd2142881fd. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:872b6c23772330f15b40470383646283343d13a2212d7677e6ad4bd2142881fd: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/protara-therapeutics-inc). - alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d: [Protara Therapeutics, Inc. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm). - alpha:projection-evidence:document:ce642dfe3e076efdaac5bf8fdc70f976f8d75dbdf3846d694ff3b1eb64857e66: [TARA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1359931/000121390026048536/ea0286228-04.htm). - alpha:projection-evidence:847fad036ba319aa19100716b06206bbe60c404b5d9c77c8bbf36dc621224545: [Audit](https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/protara-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/protara-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/protara-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-17T05:23:52.679197+00:00; recorded 2026-10-17T05:23:52.679197+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.